Coronavirus Testing Trials -- Professor Sarah Gilbert Interview

Professor Sarah Gilbert explains the composition and mechanism of a new vaccine using an adenovirus vector to deliver the coronavirus spike protein, inducing an immune response. The vaccine is designed to be safe, unable to replicate or cause disease. It triggers both antibody and T cell responses, providing protection against the virus. Gilbert expresses high confidence in the vaccine's effectiveness, based on previous successful studies with similar technology, but emphasizes the need for human testing before widespread use.

What is the primary role of the adenovirus in the vaccine?

• To cause a mild infection

• To deliver the spike protein gene

• To act as a placebo

• To replicate within the body

How does the immune system respond to the spike protein delivered by the vaccine?

• It produces antibodies and T cells

• It causes an allergic reaction

• It ignores the protein as harmless

• It attacks the adenovirus

What is the function of T cells in the immune response to the vaccine?

• To destroy infected cells

• To create antibodies

• To produce more spike proteins

• To replicate the adenovirus

Why is Sarah Gilbert confident about the vaccine's effectiveness?

• Due to successful animal studies and past experience

• Because it has been used in humans already

• Due to its quick production time

• Because it is the only vaccine available

What is the next step before the vaccine can be widely used?

• Completion of human efficacy studies

• Approval from the government

• Immediate distribution to the public

• Manufacturing at a large scale